Intervention

Sildenafil citrate

ClinicalTrials.gov intervention label

Clinical trials10
Recruiting0
Common conditions7
Lead sponsors shown4

Clinical trials

10 shown
SPHERIC-1. Sildenafil and Pulmonary HypERtension In COPDNCT01441934 · 2010-10-01
UNKNOWN
To Assess The Efficacy and Safety Of Oral Sildenafil in the Treatment of Pulmonary Arterial Hypertension.NCT00430716 · 2008-04-08
TERMINATED
Sildenafil Citrate for the Treatment of Established Pre-EclampsiaNCT00141310 · 2004-09-01
TERMINATED
Effect of Regular Sildenafil on Blood Pressure and Arterial Function in HypertensionNCT00317421 · 2004-03-01
COMPLETED
A Long Term Extension Study Evaluating Safety Of Sildenafil Citrate When Used To Treat Pulmonary Arterial Hypertension (PAH) In ChildrenNCT00159874 · 2004-01-01
COMPLETED
A Randomized, Double-Blind, Placebo-Controlled Study of Sildenafil in Children With Pulmonary Arterial Hypertension.NCT00159913 · 2003-08-01
COMPLETED
The Efficacy and Safety of Sildenafil Citrate Used in Combination With Intravenous Epoprostenol in PAHNCT00159861 · 2003-07-01
COMPLETED
Study to Assess the Longterm Safety of Sildenafil Citrate in Patients With Pulmonary Arterial HypertensionNCT00159887 · 2002-12-01
COMPLETED
Nerve-Sparing Radical Prostatectomy With or Without Nerve Grafting Followed by Standard Therapy for Erectile Dysfunction in Treating Patients With Localized Prostate CancerNCT00080808 · 2001-08-01
COMPLETED
Open Label Access Study Of Sildenafil In Adult Patients With Pulmonary Arterial Hypertension Completing A1481244 StudyNCT00878943
NO_LONGER_AVAILABLE

Trial status mix

COMPLETED6
TERMINATED2
NO_LONGER_AVAILABLE1
UNKNOWN1

Phase mix

PHASE35
PHASE23
PHASE41

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.